nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—SLC22A7—Fluorouracil—head and neck cancer	0.246	0.302	CbGbCtD
Clarithromycin—SLC22A7—Docetaxel—head and neck cancer	0.188	0.231	CbGbCtD
Clarithromycin—CYP3A7—Docetaxel—head and neck cancer	0.0728	0.0896	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0728	0.0896	CbGbCtD
Clarithromycin—CYP3A5—Docetaxel—head and neck cancer	0.0546	0.0672	CbGbCtD
Clarithromycin—CYP1A2—Fluorouracil—head and neck cancer	0.0532	0.0655	CbGbCtD
Clarithromycin—ABCB1—Vinblastine—head and neck cancer	0.0431	0.0531	CbGbCtD
Clarithromycin—ABCB1—Docetaxel—head and neck cancer	0.0355	0.0437	CbGbCtD
Clarithromycin—CYP3A4—Vinblastine—head and neck cancer	0.0258	0.0318	CbGbCtD
Clarithromycin—CYP3A4—Docetaxel—head and neck cancer	0.0213	0.0262	CbGbCtD
Clarithromycin—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.00304	0.0179	CcSEcCtD
Clarithromycin—Platelet count decreased—Hydroxyurea—head and neck cancer	0.003	0.0177	CcSEcCtD
Clarithromycin—Eruption—Hydroxyurea—head and neck cancer	0.0029	0.0171	CcSEcCtD
Clarithromycin—Enteritis—Docetaxel—head and neck cancer	0.00271	0.016	CcSEcCtD
Clarithromycin—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.00231	0.0136	CcSEcCtD
Clarithromycin—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.00219	0.0129	CcSEcCtD
Clarithromycin—Cellulitis—Vinblastine—head and neck cancer	0.00215	0.0127	CcSEcCtD
Clarithromycin—Heartburn—Fluorouracil—head and neck cancer	0.00187	0.011	CcSEcCtD
Clarithromycin—Photophobia—Vinblastine—head and neck cancer	0.00184	0.0108	CcSEcCtD
Clarithromycin—Neoplasm—Vinblastine—head and neck cancer	0.00177	0.0104	CcSEcCtD
Clarithromycin—Blood urea increased—Hydroxyurea—head and neck cancer	0.00169	0.00991	CcSEcCtD
Clarithromycin—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00162	0.00954	CcSEcCtD
Clarithromycin—Neoplasm—Hydroxyurea—head and neck cancer	0.00161	0.00949	CcSEcCtD
Clarithromycin—Deafness—Vinblastine—head and neck cancer	0.00159	0.00934	CcSEcCtD
Clarithromycin—Polyp—Docetaxel—head and neck cancer	0.00152	0.00897	CcSEcCtD
Clarithromycin—Eruption—Docetaxel—head and neck cancer	0.00151	0.00887	CcSEcCtD
Clarithromycin—Oral candidiasis—Docetaxel—head and neck cancer	0.00146	0.00859	CcSEcCtD
Clarithromycin—Disorientation—Hydroxyurea—head and neck cancer	0.00145	0.00852	CcSEcCtD
Clarithromycin—Hepatic failure—Hydroxyurea—head and neck cancer	0.00144	0.00848	CcSEcCtD
Clarithromycin—Parosmia—Docetaxel—head and neck cancer	0.00143	0.00841	CcSEcCtD
Clarithromycin—Cellulitis—Fluorouracil—head and neck cancer	0.00141	0.00831	CcSEcCtD
Clarithromycin—Cyst—Docetaxel—head and neck cancer	0.00139	0.00816	CcSEcCtD
Clarithromycin—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00136	0.00798	CcSEcCtD
Clarithromycin—Heartburn—Docetaxel—head and neck cancer	0.00135	0.00793	CcSEcCtD
Clarithromycin—Haemoglobin decreased—Docetaxel—head and neck cancer	0.00135	0.00793	CcSEcCtD
Clarithromycin—SLC22A7—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.0013	0.0736	CbGpPWpGaD
Clarithromycin—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00121	0.00714	CcSEcCtD
Clarithromycin—Photophobia—Fluorouracil—head and neck cancer	0.00121	0.0071	CcSEcCtD
Clarithromycin—Hepatotoxicity—Docetaxel—head and neck cancer	0.0012	0.00707	CcSEcCtD
Clarithromycin—Otitis media—Docetaxel—head and neck cancer	0.00119	0.00701	CcSEcCtD
Clarithromycin—Oesophagitis—Fluorouracil—head and neck cancer	0.00117	0.00691	CcSEcCtD
Clarithromycin—Breast disorder—Hydroxyurea—head and neck cancer	0.00117	0.00689	CcSEcCtD
Clarithromycin—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00117	0.00687	CcSEcCtD
Clarithromycin—Ageusia—Docetaxel—head and neck cancer	0.00114	0.00673	CcSEcCtD
Clarithromycin—Pancreatitis—Hydroxyurea—head and neck cancer	0.0011	0.00646	CcSEcCtD
Clarithromycin—Depression—Vinblastine—head and neck cancer	0.00109	0.00642	CcSEcCtD
Clarithromycin—Dysuria—Hydroxyurea—head and neck cancer	0.00105	0.00616	CcSEcCtD
Clarithromycin—Neutropenia—Hydroxyurea—head and neck cancer	0.00105	0.00616	CcSEcCtD
Clarithromycin—Disorientation—Fluorouracil—head and neck cancer	0.00104	0.00613	CcSEcCtD
Clarithromycin—Agranulocytosis—Vinblastine—head and neck cancer	0.00102	0.00601	CcSEcCtD
Clarithromycin—Drug interaction—Docetaxel—head and neck cancer	0.001	0.00588	CcSEcCtD
Clarithromycin—Infestation NOS—Hydroxyurea—head and neck cancer	0.000999	0.00587	CcSEcCtD
Clarithromycin—Infestation—Hydroxyurea—head and neck cancer	0.000999	0.00587	CcSEcCtD
Clarithromycin—Haemoglobin—Vinblastine—head and neck cancer	0.000988	0.00581	CcSEcCtD
Clarithromycin—Haemorrhage—Vinblastine—head and neck cancer	0.000983	0.00578	CcSEcCtD
Clarithromycin—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.000981	0.0556	CbGpPWpGaD
Clarithromycin—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00098	0.00577	CcSEcCtD
Clarithromycin—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000976	0.00574	CcSEcCtD
Clarithromycin—Pharyngitis—Vinblastine—head and neck cancer	0.000976	0.00574	CcSEcCtD
Clarithromycin—Hearing impaired—Docetaxel—head and neck cancer	0.000974	0.00573	CcSEcCtD
Clarithromycin—Stomatitis—Hydroxyurea—head and neck cancer	0.000973	0.00573	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000944	0.00556	CcSEcCtD
Clarithromycin—Pulmonary embolism—Docetaxel—head and neck cancer	0.000927	0.00546	CcSEcCtD
Clarithromycin—Haemoglobin—Hydroxyurea—head and neck cancer	0.000901	0.0053	CcSEcCtD
Clarithromycin—Haemorrhage—Hydroxyurea—head and neck cancer	0.000896	0.00527	CcSEcCtD
Clarithromycin—Hallucination—Hydroxyurea—head and neck cancer	0.000892	0.00525	CcSEcCtD
Clarithromycin—Cardiac arrest—Fluorouracil—head and neck cancer	0.000887	0.00522	CcSEcCtD
Clarithromycin—Candida infection—Docetaxel—head and neck cancer	0.000885	0.00521	CcSEcCtD
Clarithromycin—SLC22A7—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.000863	0.0489	CbGpPWpGaD
Clarithromycin—Oesophagitis—Docetaxel—head and neck cancer	0.000847	0.00499	CcSEcCtD
Clarithromycin—Neoplasm—Docetaxel—head and neck cancer	0.000838	0.00493	CcSEcCtD
Clarithromycin—Angiopathy—Hydroxyurea—head and neck cancer	0.000813	0.00478	CcSEcCtD
Clarithromycin—Chills—Hydroxyurea—head and neck cancer	0.000804	0.00473	CcSEcCtD
Clarithromycin—Eosinophilia—Fluorouracil—head and neck cancer	0.000798	0.0047	CcSEcCtD
Clarithromycin—Ill-defined disorder—Vinblastine—head and neck cancer	0.000794	0.00467	CcSEcCtD
Clarithromycin—Anaemia—Vinblastine—head and neck cancer	0.000791	0.00465	CcSEcCtD
Clarithromycin—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000774	0.00455	CcSEcCtD
Clarithromycin—Malaise—Vinblastine—head and neck cancer	0.000772	0.00454	CcSEcCtD
Clarithromycin—Vertigo—Vinblastine—head and neck cancer	0.000769	0.00452	CcSEcCtD
Clarithromycin—Leukopenia—Vinblastine—head and neck cancer	0.000766	0.00451	CcSEcCtD
Clarithromycin—Deafness—Docetaxel—head and neck cancer	0.000753	0.00443	CcSEcCtD
Clarithromycin—Hepatic failure—Docetaxel—head and neck cancer	0.000749	0.00441	CcSEcCtD
Clarithromycin—Convulsion—Vinblastine—head and neck cancer	0.000741	0.00436	CcSEcCtD
Clarithromycin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000724	0.00426	CcSEcCtD
Clarithromycin—Pneumonia—Fluorouracil—head and neck cancer	0.000723	0.00425	CcSEcCtD
Clarithromycin—Anaemia—Hydroxyurea—head and neck cancer	0.000721	0.00424	CcSEcCtD
Clarithromycin—Discomfort—Vinblastine—head and neck cancer	0.00072	0.00423	CcSEcCtD
Clarithromycin—Infestation—Fluorouracil—head and neck cancer	0.000719	0.00423	CcSEcCtD
Clarithromycin—Infestation NOS—Fluorouracil—head and neck cancer	0.000719	0.00423	CcSEcCtD
Clarithromycin—Atrial fibrillation—Docetaxel—head and neck cancer	0.00071	0.00418	CcSEcCtD
Clarithromycin—Visual disturbance—Docetaxel—head and neck cancer	0.00071	0.00418	CcSEcCtD
Clarithromycin—Renal impairment—Docetaxel—head and neck cancer	0.000707	0.00416	CcSEcCtD
Clarithromycin—Dermatitis bullous—Docetaxel—head and neck cancer	0.000704	0.00414	CcSEcCtD
Clarithromycin—Malaise—Hydroxyurea—head and neck cancer	0.000704	0.00414	CcSEcCtD
Clarithromycin—Stomatitis—Fluorouracil—head and neck cancer	0.000701	0.00412	CcSEcCtD
Clarithromycin—Conjunctivitis—Fluorouracil—head and neck cancer	0.000699	0.00411	CcSEcCtD
Clarithromycin—Leukopenia—Hydroxyurea—head and neck cancer	0.000699	0.00411	CcSEcCtD
Clarithromycin—Thrombocytopenia—Vinblastine—head and neck cancer	0.000684	0.00402	CcSEcCtD
Clarithromycin—Epistaxis—Fluorouracil—head and neck cancer	0.000678	0.00399	CcSEcCtD
Clarithromycin—Convulsion—Hydroxyurea—head and neck cancer	0.000676	0.00398	CcSEcCtD
Clarithromycin—Agranulocytosis—Fluorouracil—head and neck cancer	0.000671	0.00395	CcSEcCtD
Clarithromycin—Anorexia—Vinblastine—head and neck cancer	0.000666	0.00392	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00066	0.00388	CcSEcCtD
Clarithromycin—Discomfort—Hydroxyurea—head and neck cancer	0.000656	0.00386	CcSEcCtD
Clarithromycin—Haemoglobin—Fluorouracil—head and neck cancer	0.000649	0.00382	CcSEcCtD
Clarithromycin—Rhinitis—Fluorouracil—head and neck cancer	0.000647	0.00381	CcSEcCtD
Clarithromycin—Haemorrhage—Fluorouracil—head and neck cancer	0.000645	0.0038	CcSEcCtD
Clarithromycin—Pharyngitis—Fluorouracil—head and neck cancer	0.00064	0.00377	CcSEcCtD
Clarithromycin—Infection—Hydroxyurea—head and neck cancer	0.000633	0.00372	CcSEcCtD
Clarithromycin—Paraesthesia—Vinblastine—head and neck cancer	0.000627	0.00369	CcSEcCtD
Clarithromycin—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000625	0.00367	CcSEcCtD
Clarithromycin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000624	0.00367	CcSEcCtD
Clarithromycin—Liver function test abnormal—Docetaxel—head and neck cancer	0.000622	0.00366	CcSEcCtD
Clarithromycin—Skin disorder—Hydroxyurea—head and neck cancer	0.000619	0.00364	CcSEcCtD
Clarithromycin—SLC22A7—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000614	0.0348	CbGpPWpGaD
Clarithromycin—Breast disorder—Docetaxel—head and neck cancer	0.000608	0.00358	CcSEcCtD
Clarithromycin—Anorexia—Hydroxyurea—head and neck cancer	0.000607	0.00357	CcSEcCtD
Clarithromycin—Decreased appetite—Vinblastine—head and neck cancer	0.000607	0.00357	CcSEcCtD
Clarithromycin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000606	0.00357	CcSEcCtD
Clarithromycin—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000606	0.00357	CcSEcCtD
Clarithromycin—Constipation—Vinblastine—head and neck cancer	0.000597	0.00351	CcSEcCtD
Clarithromycin—Pain—Vinblastine—head and neck cancer	0.000597	0.00351	CcSEcCtD
Clarithromycin—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000594	0.00349	CcSEcCtD
Clarithromycin—Feeling abnormal—Vinblastine—head and neck cancer	0.000575	0.00339	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000571	0.00336	CcSEcCtD
Clarithromycin—Dyspnoea—Hydroxyurea—head and neck cancer	0.000568	0.00334	CcSEcCtD
Clarithromycin—Somnolence—Hydroxyurea—head and neck cancer	0.000566	0.00333	CcSEcCtD
Clarithromycin—Dyspepsia—Hydroxyurea—head and neck cancer	0.000561	0.0033	CcSEcCtD
Clarithromycin—Decreased appetite—Hydroxyurea—head and neck cancer	0.000554	0.00326	CcSEcCtD
Clarithromycin—Abdominal pain—Vinblastine—head and neck cancer	0.000552	0.00325	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00055	0.00323	CcSEcCtD
Clarithromycin—Fatigue—Hydroxyurea—head and neck cancer	0.000549	0.00323	CcSEcCtD
Clarithromycin—Pain—Hydroxyurea—head and neck cancer	0.000545	0.0032	CcSEcCtD
Clarithromycin—Constipation—Hydroxyurea—head and neck cancer	0.000545	0.0032	CcSEcCtD
Clarithromycin—Neutropenia—Docetaxel—head and neck cancer	0.000544	0.0032	CcSEcCtD
Clarithromycin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000525	0.00309	CcSEcCtD
Clarithromycin—Pneumonia—Docetaxel—head and neck cancer	0.000522	0.00307	CcSEcCtD
Clarithromycin—Anaemia—Fluorouracil—head and neck cancer	0.000519	0.00305	CcSEcCtD
Clarithromycin—Infestation NOS—Docetaxel—head and neck cancer	0.000519	0.00305	CcSEcCtD
Clarithromycin—Infestation—Docetaxel—head and neck cancer	0.000519	0.00305	CcSEcCtD
Clarithromycin—Hypersensitivity—Vinblastine—head and neck cancer	0.000515	0.00303	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000514	0.00303	CcSEcCtD
Clarithromycin—Renal failure—Docetaxel—head and neck cancer	0.00051	0.003	CcSEcCtD
Clarithromycin—Stomatitis—Docetaxel—head and neck cancer	0.000506	0.00297	CcSEcCtD
Clarithromycin—Jaundice—Docetaxel—head and neck cancer	0.000506	0.00297	CcSEcCtD
Clarithromycin—Conjunctivitis—Docetaxel—head and neck cancer	0.000504	0.00297	CcSEcCtD
Clarithromycin—Body temperature increased—Hydroxyurea—head and neck cancer	0.000503	0.00296	CcSEcCtD
Clarithromycin—Leukopenia—Fluorouracil—head and neck cancer	0.000503	0.00296	CcSEcCtD
Clarithromycin—Asthenia—Vinblastine—head and neck cancer	0.000501	0.00295	CcSEcCtD
Clarithromycin—SLC22A7—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000492	0.0279	CbGpPWpGaD
Clarithromycin—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000491	0.00289	CcSEcCtD
Clarithromycin—Epistaxis—Docetaxel—head and neck cancer	0.000489	0.00288	CcSEcCtD
Clarithromycin—Convulsion—Fluorouracil—head and neck cancer	0.000487	0.00286	CcSEcCtD
Clarithromycin—Agranulocytosis—Docetaxel—head and neck cancer	0.000484	0.00285	CcSEcCtD
Clarithromycin—Chest pain—Fluorouracil—head and neck cancer	0.000478	0.00281	CcSEcCtD
Clarithromycin—Myalgia—Fluorouracil—head and neck cancer	0.000478	0.00281	CcSEcCtD
Clarithromycin—Diarrhoea—Vinblastine—head and neck cancer	0.000478	0.00281	CcSEcCtD
Clarithromycin—Discomfort—Fluorouracil—head and neck cancer	0.000472	0.00278	CcSEcCtD
Clarithromycin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000469	0.00276	CcSEcCtD
Clarithromycin—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000468	0.0266	CbGpPWpGaD
Clarithromycin—Haemoglobin—Docetaxel—head and neck cancer	0.000468	0.00275	CcSEcCtD
Clarithromycin—Rhinitis—Docetaxel—head and neck cancer	0.000467	0.00275	CcSEcCtD
Clarithromycin—Haemorrhage—Docetaxel—head and neck cancer	0.000466	0.00274	CcSEcCtD
Clarithromycin—Hepatitis—Docetaxel—head and neck cancer	0.000466	0.00274	CcSEcCtD
Clarithromycin—Confusional state—Fluorouracil—head and neck cancer	0.000462	0.00272	CcSEcCtD
Clarithromycin—Pharyngitis—Docetaxel—head and neck cancer	0.000462	0.00272	CcSEcCtD
Clarithromycin—Dizziness—Vinblastine—head and neck cancer	0.000462	0.00272	CcSEcCtD
Clarithromycin—Urinary tract disorder—Docetaxel—head and neck cancer	0.00046	0.00271	CcSEcCtD
Clarithromycin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000458	0.0027	CcSEcCtD
Clarithromycin—Connective tissue disorder—Docetaxel—head and neck cancer	0.000458	0.00269	CcSEcCtD
Clarithromycin—Asthenia—Hydroxyurea—head and neck cancer	0.000457	0.00269	CcSEcCtD
Clarithromycin—Urethral disorder—Docetaxel—head and neck cancer	0.000457	0.00269	CcSEcCtD
Clarithromycin—Infection—Fluorouracil—head and neck cancer	0.000455	0.00268	CcSEcCtD
Clarithromycin—Nervous system disorder—Fluorouracil—head and neck cancer	0.00045	0.00264	CcSEcCtD
Clarithromycin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000449	0.00264	CcSEcCtD
Clarithromycin—Visual impairment—Docetaxel—head and neck cancer	0.000449	0.00264	CcSEcCtD
Clarithromycin—Vomiting—Vinblastine—head and neck cancer	0.000444	0.00261	CcSEcCtD
Clarithromycin—Erythema multiforme—Docetaxel—head and neck cancer	0.00044	0.00259	CcSEcCtD
Clarithromycin—Headache—Vinblastine—head and neck cancer	0.000437	0.00257	CcSEcCtD
Clarithromycin—Anorexia—Fluorouracil—head and neck cancer	0.000437	0.00257	CcSEcCtD
Clarithromycin—Diarrhoea—Hydroxyurea—head and neck cancer	0.000436	0.00256	CcSEcCtD
Clarithromycin—Eye disorder—Docetaxel—head and neck cancer	0.000435	0.00256	CcSEcCtD
Clarithromycin—Cardiac disorder—Docetaxel—head and neck cancer	0.000432	0.00254	CcSEcCtD
Clarithromycin—Flushing—Docetaxel—head and neck cancer	0.000432	0.00254	CcSEcCtD
Clarithromycin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000428	0.0243	CbGpPWpGaD
Clarithromycin—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000426	0.0242	CbGpPWpGaD
Clarithromycin—Angiopathy—Docetaxel—head and neck cancer	0.000423	0.00249	CcSEcCtD
Clarithromycin—Dizziness—Hydroxyurea—head and neck cancer	0.000421	0.00248	CcSEcCtD
Clarithromycin—Immune system disorder—Docetaxel—head and neck cancer	0.000421	0.00247	CcSEcCtD
Clarithromycin—Mediastinal disorder—Docetaxel—head and neck cancer	0.00042	0.00247	CcSEcCtD
Clarithromycin—Chills—Docetaxel—head and neck cancer	0.000418	0.00246	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000418	0.00246	CcSEcCtD
Clarithromycin—Nausea—Vinblastine—head and neck cancer	0.000415	0.00244	CcSEcCtD
Clarithromycin—Insomnia—Fluorouracil—head and neck cancer	0.000415	0.00244	CcSEcCtD
Clarithromycin—Paraesthesia—Fluorouracil—head and neck cancer	0.000412	0.00242	CcSEcCtD
Clarithromycin—Dyspnoea—Fluorouracil—head and neck cancer	0.000409	0.0024	CcSEcCtD
Clarithromycin—Mental disorder—Docetaxel—head and neck cancer	0.000408	0.0024	CcSEcCtD
Clarithromycin—Somnolence—Fluorouracil—head and neck cancer	0.000408	0.0024	CcSEcCtD
Clarithromycin—Malnutrition—Docetaxel—head and neck cancer	0.000405	0.00238	CcSEcCtD
Clarithromycin—Vomiting—Hydroxyurea—head and neck cancer	0.000405	0.00238	CcSEcCtD
Clarithromycin—Dyspepsia—Fluorouracil—head and neck cancer	0.000404	0.00237	CcSEcCtD
Clarithromycin—CYP3A7—Xenobiotics—CYP1A1—head and neck cancer	0.000403	0.0228	CbGpPWpGaD
Clarithromycin—Rash—Hydroxyurea—head and neck cancer	0.000402	0.00236	CcSEcCtD
Clarithromycin—Dermatitis—Hydroxyurea—head and neck cancer	0.000401	0.00236	CcSEcCtD
Clarithromycin—Headache—Hydroxyurea—head and neck cancer	0.000399	0.00235	CcSEcCtD
Clarithromycin—Decreased appetite—Fluorouracil—head and neck cancer	0.000398	0.00234	CcSEcCtD
Clarithromycin—Dysgeusia—Docetaxel—head and neck cancer	0.000397	0.00234	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000396	0.00233	CcSEcCtD
Clarithromycin—Back pain—Docetaxel—head and neck cancer	0.000392	0.00231	CcSEcCtD
Clarithromycin—Pain—Fluorouracil—head and neck cancer	0.000392	0.00231	CcSEcCtD
Clarithromycin—Muscle spasms—Docetaxel—head and neck cancer	0.00039	0.00229	CcSEcCtD
Clarithromycin—Nausea—Hydroxyurea—head and neck cancer	0.000378	0.00223	CcSEcCtD
Clarithromycin—Feeling abnormal—Fluorouracil—head and neck cancer	0.000378	0.00222	CcSEcCtD
Clarithromycin—Anaemia—Docetaxel—head and neck cancer	0.000375	0.0022	CcSEcCtD
Clarithromycin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000365	0.0207	CbGpPWpGaD
Clarithromycin—Urticaria—Fluorouracil—head and neck cancer	0.000364	0.00214	CcSEcCtD
Clarithromycin—Leukopenia—Docetaxel—head and neck cancer	0.000363	0.00213	CcSEcCtD
Clarithromycin—Body temperature increased—Fluorouracil—head and neck cancer	0.000362	0.00213	CcSEcCtD
Clarithromycin—Palpitations—Docetaxel—head and neck cancer	0.000358	0.00211	CcSEcCtD
Clarithromycin—Loss of consciousness—Docetaxel—head and neck cancer	0.000356	0.0021	CcSEcCtD
Clarithromycin—Cough—Docetaxel—head and neck cancer	0.000354	0.00208	CcSEcCtD
Clarithromycin—Convulsion—Docetaxel—head and neck cancer	0.000351	0.00207	CcSEcCtD
Clarithromycin—Myalgia—Docetaxel—head and neck cancer	0.000345	0.00203	CcSEcCtD
Clarithromycin—Chest pain—Docetaxel—head and neck cancer	0.000345	0.00203	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000343	0.00202	CcSEcCtD
Clarithromycin—Hypersensitivity—Fluorouracil—head and neck cancer	0.000338	0.00199	CcSEcCtD
Clarithromycin—Dry mouth—Docetaxel—head and neck cancer	0.000338	0.00199	CcSEcCtD
Clarithromycin—Confusional state—Docetaxel—head and neck cancer	0.000334	0.00196	CcSEcCtD
Clarithromycin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000332	0.0188	CbGpPWpGaD
Clarithromycin—Anaphylactic shock—Docetaxel—head and neck cancer	0.000331	0.00195	CcSEcCtD
Clarithromycin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000331	0.0188	CbGpPWpGaD
Clarithromycin—Infection—Docetaxel—head and neck cancer	0.000329	0.00193	CcSEcCtD
Clarithromycin—Nervous system disorder—Docetaxel—head and neck cancer	0.000324	0.00191	CcSEcCtD
Clarithromycin—Pruritus—Fluorouracil—head and neck cancer	0.000324	0.00191	CcSEcCtD
Clarithromycin—Thrombocytopenia—Docetaxel—head and neck cancer	0.000324	0.00191	CcSEcCtD
Clarithromycin—Skin disorder—Docetaxel—head and neck cancer	0.000321	0.00189	CcSEcCtD
Clarithromycin—Anorexia—Docetaxel—head and neck cancer	0.000315	0.00186	CcSEcCtD
Clarithromycin—Diarrhoea—Fluorouracil—head and neck cancer	0.000314	0.00185	CcSEcCtD
Clarithromycin—Dizziness—Fluorouracil—head and neck cancer	0.000303	0.00178	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000301	0.00177	CcSEcCtD
Clarithromycin—Insomnia—Docetaxel—head and neck cancer	0.000299	0.00176	CcSEcCtD
Clarithromycin—Paraesthesia—Docetaxel—head and neck cancer	0.000297	0.00175	CcSEcCtD
Clarithromycin—Dyspnoea—Docetaxel—head and neck cancer	0.000295	0.00174	CcSEcCtD
Clarithromycin—Somnolence—Docetaxel—head and neck cancer	0.000294	0.00173	CcSEcCtD
Clarithromycin—Vomiting—Fluorouracil—head and neck cancer	0.000291	0.00171	CcSEcCtD
Clarithromycin—Dyspepsia—Docetaxel—head and neck cancer	0.000291	0.00171	CcSEcCtD
Clarithromycin—CYP3A5—Xenobiotics—CYP1A1—head and neck cancer	0.000291	0.0165	CbGpPWpGaD
Clarithromycin—Rash—Fluorouracil—head and neck cancer	0.000289	0.0017	CcSEcCtD
Clarithromycin—Dermatitis—Fluorouracil—head and neck cancer	0.000289	0.0017	CcSEcCtD
Clarithromycin—Decreased appetite—Docetaxel—head and neck cancer	0.000288	0.00169	CcSEcCtD
Clarithromycin—Headache—Fluorouracil—head and neck cancer	0.000287	0.00169	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000286	0.00168	CcSEcCtD
Clarithromycin—Fatigue—Docetaxel—head and neck cancer	0.000285	0.00168	CcSEcCtD
Clarithromycin—Pain—Docetaxel—head and neck cancer	0.000283	0.00166	CcSEcCtD
Clarithromycin—Constipation—Docetaxel—head and neck cancer	0.000283	0.00166	CcSEcCtD
Clarithromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000281	0.0159	CbGpPWpGaD
Clarithromycin—CYP3A5—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00028	0.0159	CbGpPWpGaD
Clarithromycin—Feeling abnormal—Docetaxel—head and neck cancer	0.000273	0.0016	CcSEcCtD
Clarithromycin—Nausea—Fluorouracil—head and neck cancer	0.000272	0.0016	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000271	0.00159	CcSEcCtD
Clarithromycin—Abdominal pain—Docetaxel—head and neck cancer	0.000262	0.00154	CcSEcCtD
Clarithromycin—Body temperature increased—Docetaxel—head and neck cancer	0.000262	0.00154	CcSEcCtD
Clarithromycin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000256	0.0145	CbGpPWpGaD
Clarithromycin—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000248	0.014	CbGpPWpGaD
Clarithromycin—Hypersensitivity—Docetaxel—head and neck cancer	0.000244	0.00143	CcSEcCtD
Clarithromycin—Asthenia—Docetaxel—head and neck cancer	0.000237	0.0014	CcSEcCtD
Clarithromycin—Pruritus—Docetaxel—head and neck cancer	0.000234	0.00138	CcSEcCtD
Clarithromycin—Diarrhoea—Docetaxel—head and neck cancer	0.000226	0.00133	CcSEcCtD
Clarithromycin—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.000225	0.0128	CbGpPWpGaD
Clarithromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000224	0.0127	CbGpPWpGaD
Clarithromycin—Dizziness—Docetaxel—head and neck cancer	0.000219	0.00129	CcSEcCtD
Clarithromycin—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000216	0.0123	CbGpPWpGaD
Clarithromycin—Vomiting—Docetaxel—head and neck cancer	0.00021	0.00124	CcSEcCtD
Clarithromycin—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00021	0.0119	CbGpPWpGaD
Clarithromycin—Rash—Docetaxel—head and neck cancer	0.000209	0.00123	CcSEcCtD
Clarithromycin—Dermatitis—Docetaxel—head and neck cancer	0.000208	0.00123	CcSEcCtD
Clarithromycin—Headache—Docetaxel—head and neck cancer	0.000207	0.00122	CcSEcCtD
Clarithromycin—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000201	0.0114	CbGpPWpGaD
Clarithromycin—Nausea—Docetaxel—head and neck cancer	0.000197	0.00116	CcSEcCtD
Clarithromycin—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000191	0.0108	CbGpPWpGaD
Clarithromycin—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000175	0.00994	CbGpPWpGaD
Clarithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000173	0.00981	CbGpPWpGaD
Clarithromycin—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000169	0.00956	CbGpPWpGaD
Clarithromycin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000167	0.00948	CbGpPWpGaD
Clarithromycin—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000167	0.00948	CbGpPWpGaD
Clarithromycin—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000165	0.00936	CbGpPWpGaD
Clarithromycin—SLC22A7—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000163	0.00925	CbGpPWpGaD
Clarithromycin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000162	0.00917	CbGpPWpGaD
Clarithromycin—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000155	0.00881	CbGpPWpGaD
Clarithromycin—CYP3A7—Biological oxidations—NAT2—head and neck cancer	0.000154	0.00872	CbGpPWpGaD
Clarithromycin—CYP3A7—Metapathway biotransformation—NAT2—head and neck cancer	0.000152	0.0086	CbGpPWpGaD
Clarithromycin—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000147	0.00835	CbGpPWpGaD
Clarithromycin—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000136	0.00769	CbGpPWpGaD
Clarithromycin—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000135	0.00767	CbGpPWpGaD
Clarithromycin—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.00013	0.00739	CbGpPWpGaD
Clarithromycin—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00013	0.00738	CbGpPWpGaD
Clarithromycin—SLC22A7—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000121	0.00688	CbGpPWpGaD
Clarithromycin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000121	0.00686	CbGpPWpGaD
Clarithromycin—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000119	0.00676	CbGpPWpGaD
Clarithromycin—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000115	0.00651	CbGpPWpGaD
Clarithromycin—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000114	0.00649	CbGpPWpGaD
Clarithromycin—CYP3A5—Biological oxidations—NAT2—head and neck cancer	0.000111	0.0063	CbGpPWpGaD
Clarithromycin—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	0.00011	0.00622	CbGpPWpGaD
Clarithromycin—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000109	0.00619	CbGpPWpGaD
Clarithromycin—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000108	0.00613	CbGpPWpGaD
Clarithromycin—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.8e-05	0.00556	CbGpPWpGaD
Clarithromycin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	9.35e-05	0.0053	CbGpPWpGaD
Clarithromycin—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	9.22e-05	0.00523	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	9.01e-05	0.00511	CbGpPWpGaD
Clarithromycin—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	9.01e-05	0.00511	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	9.01e-05	0.00511	CbGpPWpGaD
Clarithromycin—CYP2C19—Biological oxidations—NAT2—head and neck cancer	8.6e-05	0.00487	CbGpPWpGaD
Clarithromycin—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	8.51e-05	0.00483	CbGpPWpGaD
Clarithromycin—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	8.48e-05	0.00481	CbGpPWpGaD
Clarithromycin—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	8.43e-05	0.00478	CbGpPWpGaD
Clarithromycin—CYP3A7—Biological oxidations—GSTM1—head and neck cancer	7.6e-05	0.00431	CbGpPWpGaD
Clarithromycin—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	7.58e-05	0.0043	CbGpPWpGaD
Clarithromycin—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	7.49e-05	0.00425	CbGpPWpGaD
Clarithromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	7.28e-05	0.00413	CbGpPWpGaD
Clarithromycin—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	7.2e-05	0.00408	CbGpPWpGaD
Clarithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	7.19e-05	0.00408	CbGpPWpGaD
Clarithromycin—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	7.1e-05	0.00403	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	7.06e-05	0.004	CbGpPWpGaD
Clarithromycin—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	6.95e-05	0.00394	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—NAT2—head and neck cancer	6.7e-05	0.0038	CbGpPWpGaD
Clarithromycin—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	6.61e-05	0.00375	CbGpPWpGaD
Clarithromycin—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	6.43e-05	0.00365	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	6.42e-05	0.00364	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—UROD—head and neck cancer	6.34e-05	0.00359	CbGpPWpGaD
Clarithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	5.9e-05	0.00335	CbGpPWpGaD
Clarithromycin—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	5.65e-05	0.00321	CbGpPWpGaD
Clarithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	5.62e-05	0.00319	CbGpPWpGaD
Clarithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	5.55e-05	0.00315	CbGpPWpGaD
Clarithromycin—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	5.49e-05	0.00311	CbGpPWpGaD
Clarithromycin—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	5.42e-05	0.00307	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	5.36e-05	0.00304	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—CASP8—head and neck cancer	5.34e-05	0.00303	CbGpPWpGaD
Clarithromycin—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	5.21e-05	0.00295	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—NAT2—head and neck cancer	5.17e-05	0.00293	CbGpPWpGaD
Clarithromycin—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	5.13e-05	0.00291	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	5.1e-05	0.00289	CbGpPWpGaD
Clarithromycin—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	5.01e-05	0.00284	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	4.96e-05	0.00282	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—UROD—head and neck cancer	4.58e-05	0.0026	CbGpPWpGaD
Clarithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	4.56e-05	0.00258	CbGpPWpGaD
Clarithromycin—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	4.25e-05	0.00241	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	4.22e-05	0.00239	CbGpPWpGaD
Clarithromycin—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	4.19e-05	0.00237	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—IL2—head and neck cancer	4.04e-05	0.00229	CbGpPWpGaD
Clarithromycin—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	4.02e-05	0.00228	CbGpPWpGaD
Clarithromycin—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	3.97e-05	0.00225	CbGpPWpGaD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	3.96e-05	0.00225	CbGpPWpGaD
Clarithromycin—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	3.88e-05	0.0022	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	3.86e-05	0.00219	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	3.8e-05	0.00215	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	3.8e-05	0.00215	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	3.8e-05	0.00215	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—UROD—head and neck cancer	3.54e-05	0.00201	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—UROD—head and neck cancer	3.46e-05	0.00196	CbGpPWpGaD
Clarithromycin—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	3.43e-05	0.00194	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	3.31e-05	0.00188	CbGpPWpGaD
Clarithromycin—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	3.26e-05	0.00185	CbGpPWpGaD
Clarithromycin—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	3.14e-05	0.00178	CbGpPWpGaD
Clarithromycin—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	3.09e-05	0.00175	CbGpPWpGaD
Clarithromycin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	3.05e-05	0.00173	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—UROD—head and neck cancer	2.76e-05	0.00156	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.75e-05	0.00156	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	2.64e-05	0.00149	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—NAT2—head and neck cancer	2.63e-05	0.00149	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	2.55e-05	0.00145	CbGpPWpGaD
Clarithromycin—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	2.53e-05	0.00143	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	2.52e-05	0.00143	CbGpPWpGaD
Clarithromycin—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	2.42e-05	0.00137	CbGpPWpGaD
Clarithromycin—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	2.39e-05	0.00135	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—DPYD—head and neck cancer	2.31e-05	0.00131	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	2.26e-05	0.00128	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—YAP1—head and neck cancer	2.19e-05	0.00124	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	2.15e-05	0.00122	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.14e-05	0.00121	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—UROD—head and neck cancer	2.13e-05	0.00121	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	1.94e-05	0.0011	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—NAT2—head and neck cancer	1.9e-05	0.00108	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.87e-05	0.00106	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.69e-05	0.00096	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—DPYD—head and neck cancer	1.67e-05	0.000945	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.6e-05	0.000908	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—YAP1—head and neck cancer	1.58e-05	0.000897	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.56e-05	0.000885	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.55e-05	0.000876	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.52e-05	0.000864	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.52e-05	0.000864	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—NAT2—head and neck cancer	1.47e-05	0.000834	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—NAT2—head and neck cancer	1.43e-05	0.000814	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.32e-05	0.000749	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—TYMS—head and neck cancer	1.31e-05	0.000745	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GSTM1—head and neck cancer	1.3e-05	0.000737	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—DPYD—head and neck cancer	1.29e-05	0.000731	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.28e-05	0.000725	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—DPYD—head and neck cancer	1.26e-05	0.000713	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—GPX1—head and neck cancer	1.24e-05	0.000705	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—CYP1A1—head and neck cancer	1.23e-05	0.000698	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—YAP1—head and neck cancer	1.22e-05	0.000694	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.22e-05	0.00069	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.2e-05	0.000683	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—YAP1—head and neck cancer	1.19e-05	0.000677	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—NAT2—head and neck cancer	1.15e-05	0.00065	CbGpPWpGaD
Clarithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.08e-05	0.000612	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—DPYD—head and neck cancer	1e-05	0.00057	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—YAP1—head and neck cancer	9.53e-06	0.00054	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—TYMS—head and neck cancer	9.5e-06	0.000539	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GSTM1—head and neck cancer	9.39e-06	0.000533	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.19e-06	0.000521	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—GPX1—head and neck cancer	8.99e-06	0.00051	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—CYP1A1—head and neck cancer	8.9e-06	0.000505	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—NAT2—head and neck cancer	8.84e-06	0.000501	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.02e-06	0.000455	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—DPYD—head and neck cancer	7.75e-06	0.00044	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—YAP1—head and neck cancer	7.36e-06	0.000417	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—TYMS—head and neck cancer	7.35e-06	0.000417	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PTGS2—head and neck cancer	7.32e-06	0.000415	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GSTM1—head and neck cancer	7.26e-06	0.000412	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—TYMS—head and neck cancer	7.17e-06	0.000407	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.16e-06	0.000406	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GSTM1—head and neck cancer	7.09e-06	0.000402	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—GPX1—head and neck cancer	6.95e-06	0.000394	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—CYP1A1—head and neck cancer	6.88e-06	0.00039	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—GPX1—head and neck cancer	6.79e-06	0.000385	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—CYP1A1—head and neck cancer	6.72e-06	0.000381	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PTEN—head and neck cancer	6.39e-06	0.000362	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.25e-06	0.000354	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—TYMS—head and neck cancer	5.72e-06	0.000325	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GSTM1—head and neck cancer	5.66e-06	0.000321	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.65e-06	0.000321	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—GPX1—head and neck cancer	5.42e-06	0.000307	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—CYP1A1—head and neck cancer	5.36e-06	0.000304	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PTGS2—head and neck cancer	5.29e-06	0.0003	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PTEN—head and neck cancer	4.62e-06	0.000262	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—PIK3CA—head and neck cancer	4.51e-06	0.000256	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—TYMS—head and neck cancer	4.42e-06	0.00025	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.41e-06	0.00025	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GSTM1—head and neck cancer	4.37e-06	0.000248	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—GPX1—head and neck cancer	4.18e-06	0.000237	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—CYP1A1—head and neck cancer	4.14e-06	0.000235	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PTGS2—head and neck cancer	4.09e-06	0.000232	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PTGS2—head and neck cancer	4e-06	0.000227	CbGpPWpGaD
Clarithromycin—CYP3A7—Metabolism—AKT1—head and neck cancer	3.68e-06	0.000209	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PTEN—head and neck cancer	3.57e-06	0.000202	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PTEN—head and neck cancer	3.48e-06	0.000198	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—PIK3CA—head and neck cancer	3.26e-06	0.000185	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PTGS2—head and neck cancer	3.19e-06	0.000181	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PTEN—head and neck cancer	2.78e-06	0.000158	CbGpPWpGaD
Clarithromycin—CYP3A5—Metabolism—AKT1—head and neck cancer	2.66e-06	0.000151	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—PIK3CA—head and neck cancer	2.52e-06	0.000143	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.46e-06	0.00014	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—PIK3CA—head and neck cancer	2.46e-06	0.000139	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PTEN—head and neck cancer	2.15e-06	0.000122	CbGpPWpGaD
Clarithromycin—CYP2C19—Metabolism—AKT1—head and neck cancer	2.06e-06	0.000117	CbGpPWpGaD
Clarithromycin—ABCB1—Metabolism—AKT1—head and neck cancer	2.01e-06	0.000114	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.96e-06	0.000111	CbGpPWpGaD
Clarithromycin—CYP1A2—Metabolism—AKT1—head and neck cancer	1.6e-06	9.09e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.51e-06	8.59e-05	CbGpPWpGaD
Clarithromycin—CYP3A4—Metabolism—AKT1—head and neck cancer	1.24e-06	7.01e-05	CbGpPWpGaD
